Anti-cancer drug design:
Gespeichert in:
| Späterer Titel: | Oncology research |
|---|---|
| Format: | Zeitschrift |
| Sprache: | English |
| Veröffentlicht: |
Oxford
Oxford Univ. Press
1985-2001
Basingstoke Macmillan 1985-1991 |
| Schlagworte: | |
| Veröffentlicht: | 1.1985 - 16.2001 |
| ISSN: | 0266-9536 1460-2148 0965-0407 |
Internformat
MARC
| LEADER | 00000nas a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV002707042 | ||
| 003 | DE-604 | ||
| 005 | 20220903093000 | ||
| 007 | t| | ||
| 008 | 991120d19852001xxk|| p| |||| 0 ||eng d | ||
| 016 | 7 | |a 013669184 |2 DE-101 | |
| 016 | 7 | |a 632693-6 |2 DE-600 | |
| 022 | |a 0266-9536 |2 6 | ||
| 035 | |a (OCoLC)231044348 | ||
| 035 | |a (DE-599)ZDB632693-6 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxk |c XA-GB | ||
| 049 | |a DE-12 |a DE-355 | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 610 |2 22sdnb | ||
| 084 | |a 15,3 |2 ssgn | ||
| 210 | 1 | 0 | |a Anticancer Drug Des |2 din1502 |
| 245 | 1 | 0 | |a Anti-cancer drug design |
| 264 | 3 | 1 | |a Oxford |b Oxford Univ. Press |c 1985-2001 |
| 264 | 2 | 1 | |a Basingstoke |b Macmillan |c 1985-1991 |
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 362 | 0 | |a 1.1985 - 16.2001 | |
| 363 | 0 | 0 | |8 1.1\x |a 1 |i 1985 |
| 363 | 1 | 0 | |8 1.2\x |a 16 |i 2001 |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zeitschrift |0 (DE-588)4067488-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4067488-5 |a Zeitschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |D s |
| 689 | 0 | 1 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 1 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 1 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
| 689 | 1 | |5 ZDB | |
| 689 | 2 | 0 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |D s |
| 689 | 2 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 2 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
| 689 | 2 | |5 ZDB | |
| 689 | 3 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 3 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 3 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
| 689 | 3 | |5 ZDB | |
| 776 | 0 | 8 | |i Online-Ausg. |t Anti-cancer drug design |d Elmsford, NY : Cognizant Communication Corporation, 1996-2001 |h Online-Ressource |x 1460-2148 |w (DE-604)BV012683624 |
| 785 | 0 | 0 | |i Aufgeg. in |t Oncology research |d Elmsford, NY : Cognizant Communication, 1992- |x 0965-0407 |w (DE-604)BV005453384 |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-001732962 | |
Datensatz im Suchindex
| _version_ | 1823607486102372352 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV002707042 |
| ctrlnum | 632693-6 (OCoLC)231044348 (DE-599)ZDB632693-6 |
| dateSpan | 1.1985 - 16.2001 |
| format | Journal |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas a2200000 c 4500</leader><controlfield tag="001">BV002707042</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220903093000</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">991120d19852001xxk|| p| |||| 0 ||eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">013669184</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">632693-6</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">0266-9536</subfield><subfield code="2">6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231044348</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB632693-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">XA-GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">22sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="210" ind1="1" ind2="0"><subfield code="a">Anticancer Drug Des</subfield><subfield code="2">din1502</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anti-cancer drug design</subfield></datafield><datafield tag="264" ind1="3" ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">1985-2001</subfield></datafield><datafield tag="264" ind1="2" ind2="1"><subfield code="a">Basingstoke</subfield><subfield code="b">Macmillan</subfield><subfield code="c">1985-1991</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="0" ind2=" "><subfield code="a">1.1985 - 16.2001</subfield></datafield><datafield tag="363" ind1="0" ind2="0"><subfield code="8">1.1\x</subfield><subfield code="a">1</subfield><subfield code="i">1985</subfield></datafield><datafield tag="363" ind1="1" ind2="0"><subfield code="8">1.2\x</subfield><subfield code="a">16</subfield><subfield code="i">2001</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumorhemmstoff</subfield><subfield code="0">(DE-588)4292869-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4067488-5</subfield><subfield code="a">Zeitschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tumorhemmstoff</subfield><subfield code="0">(DE-588)4292869-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">ZDB</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Tumorhemmstoff</subfield><subfield code="0">(DE-588)4292869-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">ZDB</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">ZDB</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Online-Ausg.</subfield><subfield code="t">Anti-cancer drug design</subfield><subfield code="d">Elmsford, NY : Cognizant Communication Corporation, 1996-2001</subfield><subfield code="h">Online-Ressource</subfield><subfield code="x">1460-2148</subfield><subfield code="w">(DE-604)BV012683624</subfield></datafield><datafield tag="785" ind1="0" ind2="0"><subfield code="i">Aufgeg. in</subfield><subfield code="t">Oncology research</subfield><subfield code="d">Elmsford, NY : Cognizant Communication, 1992-</subfield><subfield code="x">0965-0407</subfield><subfield code="w">(DE-604)BV005453384</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001732962</subfield></datafield></record></collection> |
| genre | (DE-588)4067488-5 Zeitschrift gnd-content |
| genre_facet | Zeitschrift |
| id | DE-604.BV002707042 |
| illustrated | Illustrated |
| indexdate | 2025-02-09T19:00:22Z |
| institution | BVB |
| issn | 0266-9536 1460-2148 0965-0407 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001732962 |
| oclc_num | 231044348 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| publishDate | 1985 |
| publishDateSearch | 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 |
| publishDateSort | 2001 |
| publisher | Oxford Univ. Press Macmillan |
| record_format | marc |
| spelling | Anticancer Drug Des din1502 Anti-cancer drug design Oxford Oxford Univ. Press 1985-2001 Basingstoke Macmillan 1985-1991 txt rdacontent n rdamedia nc rdacarrier 1.1985 - 16.2001 1.1\x 1 1985 1.2\x 16 2001 Cytostatikum (DE-588)4068347-3 gnd rswk-swf Zeitschrift (DE-588)4067488-5 gnd rswk-swf Tumorhemmstoff (DE-588)4292869-2 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf (DE-588)4067488-5 Zeitschrift gnd-content Tumorhemmstoff (DE-588)4292869-2 s Arzneimitteldesign (DE-588)4278218-1 s Zeitschrift (DE-588)4067488-5 s DE-604 Cytostatikum (DE-588)4068347-3 s ZDB Pharmakologie (DE-588)4045687-0 s Online-Ausg. Anti-cancer drug design Elmsford, NY : Cognizant Communication Corporation, 1996-2001 Online-Ressource 1460-2148 (DE-604)BV012683624 Aufgeg. in Oncology research Elmsford, NY : Cognizant Communication, 1992- 0965-0407 (DE-604)BV005453384 |
| spellingShingle | Anti-cancer drug design Cytostatikum (DE-588)4068347-3 gnd Zeitschrift (DE-588)4067488-5 gnd Tumorhemmstoff (DE-588)4292869-2 gnd Pharmakologie (DE-588)4045687-0 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4067488-5 (DE-588)4292869-2 (DE-588)4045687-0 (DE-588)4278218-1 |
| title | Anti-cancer drug design |
| title_auth | Anti-cancer drug design |
| title_exact_search | Anti-cancer drug design |
| title_full | Anti-cancer drug design |
| title_fullStr | Anti-cancer drug design |
| title_full_unstemmed | Anti-cancer drug design |
| title_new | Oncology research |
| title_short | Anti-cancer drug design |
| title_sort | anti cancer drug design |
| topic | Cytostatikum (DE-588)4068347-3 gnd Zeitschrift (DE-588)4067488-5 gnd Tumorhemmstoff (DE-588)4292869-2 gnd Pharmakologie (DE-588)4045687-0 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| topic_facet | Cytostatikum Zeitschrift Tumorhemmstoff Pharmakologie Arzneimitteldesign |
| zdb_num | 632693-6 (DE-599)ZDB632693-6 |